
A proposed Sandoz biosimilar of pegfilgrastim (Neulasta) demonstrated biosimilarity to the reference biologic.

A proposed Sandoz biosimilar of pegfilgrastim (Neulasta) demonstrated biosimilarity to the reference biologic.

A high number of patients with eosinophilic granulomatosis treated with mepolizumab achieve remission within 24 weeks compared with placebo patients.

Patients taking hydrochlorothiazide may be 7 times more likely to develop squamous cell carcinoma.

The presence of a nerve protein in the blood may indicate the development of new T1 and T2 lesions resulting from multiple sclerosis.

These findings could lead to novel a HIV vaccine.

Top news of the day from across the health care landscape.

Galcanezumab found to significantly decrease the average number of monthly migraine headache days.

This extended-release injectable suspension aims to prevent relapse in opioid-dependent patients after detox and treat alcoholism.

Diplomat Pharmacy Inc.’s Acquisition of National Pharmaceutical Services will improve patient management services.

Online consultations may reduce the need for in-person appointments, but challenges can still arise.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, discusses how proposed legislations would affect pharmacy benefit manager relations with specialty pharmacies.

Ibrutinib (Imbruvica) plus rituximab increased progression-free survival among patients with Waldenström's macroglobulinemia.

Nearly 30,000 individuals were diagnosed with HIV in the European Region in 2016.

Top news of the day from across the health care landscape.

A small number of multiple sclerosis cases following vaccinations affected compliance with vaccination recommendations.

Patients with cancer and caregivers said that the internet helped them to make informed care-related decisions.

An investigational HIV drug may be able to cross the blood-brain barrier and prevent adverse events.

John Giannouris, vice president, Specialty Pharmacy Services, ValueCentric, discusses how data connectivity is crucial for the specialty pharmacy industry.

PD-L1-based immunotherapy observed to elicit long-lasting diabetes reversal in mice.

Top news of the day from across the health care landscape.

Top news of the week from Specialty Pharmacy Times.

Doctors are less likely to prescribe common cardiovascular prevention and intervention therapies to HIV-positive patients.

Medication histories taken by pharmacists and pharmacy technicians significantly reduced medication errors.

Starting an adherence program for patients with HIV may mitigate costs for universal treatment protocols.

Up to 90% of patients with psoriasis develop plaque on their nails, palms of the hands, and soles of the feet.

Cell structure may allow immune cells to attack myelin in multiple sclerosis.

Top news of the day from across the health care landscape.

Hay fever and asthma are dependent on allergens that stimulate the immunoglobulin E pathway, which is not the case with atopic dermatitis.

Age-related health issues affect people living with HIV infection at an accelerated rate.

Bevacizumab (Avastin) previously received provisional approval from the FDA.